MedTrace Logo

Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block

NCT06381622 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2025-02-17

No results posted yet for this study

Summary

The aim of the study is to investigate how the combination of ropivacaine (a slow onset, long duration local anesthetic) with lidocaine (a rapid onset, shorter duration local anesthetic) affects the onset and duration of a lateral infraclavicular plexus brachialis (LIC) block in patients undergoing non-acute hand surgery.

Conditions

  • Nerve Block
  • Anesthesia, Local
  • Forearm Fracture
  • Surgery
  • Brachial Plexus Block

Interventions

DRUG

Ropivacaine 0.5% Injectable Solution

30 mL Ropivacaine 5 mg/mL (= 150 mg Ropivacaine)

DRUG

Lidocaine epinephrine

20 mL Ropivacaine 5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg) / ml (= 100 mg Ropivacaine + 200 mg Lidocaine)

DRUG

Ropivacaine 0.75% Injectable Solution

20 mL Ropivacaine 7,5 mg/mL + 10 mL Lidocaine-Epinephrine (20 mg + 5 μg)/mL (= 150 mg Ropivacaine + 200 mg Lidocaine)

Sponsors & Collaborators

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Christian Rothe, PhD · Nordsjællands Hospital, Københavns Universitet, Hillerød

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-18
Primary Completion
2024-10-24
Completion
2024-11-23

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06381622 on ClinicalTrials.gov